122 related articles for article (PubMed ID: 17371382)
21. Dominant-negative inhibition of Ets 1 suppresses tumor growth, invasion and migration in rat C6 glioma cells and reveals differentially expressed Ets 1 target genes.
Sahin A; Vercamer C; Kaminski A; Fuchs T; Florin A; Hahne JC; Mattot V; Pourtier-Manzanedo A; Pietsch T; Fafeur V; Wernert N
Int J Oncol; 2009 Feb; 34(2):377-89. PubMed ID: 19148472
[TBL] [Abstract][Full Text] [Related]
22. Analysis of vascular gene expression in arthritic synovium by laser-mediated microdissection.
Hashimoto A; Tarner IH; Bohle RM; Gaumann A; Manetti M; Distler O; Steinmeyer J; Ulfgren AK; Schulz A; Gay S; Müller-Ladner U; Neumann E
Arthritis Rheum; 2007 Apr; 56(4):1094-105. PubMed ID: 17393418
[TBL] [Abstract][Full Text] [Related]
23. Expression and clinical significance of latent membrane protein-1, matrix metalloproteinase-1 and Ets-1 transcription factor in tunisian nasopharyngeal carcinoma patients.
Ben Nasr H; Chahed K; Remadi S; Zakhama A; Chouchane L
Arch Med Res; 2009 Apr; 40(3):196-203. PubMed ID: 19427971
[TBL] [Abstract][Full Text] [Related]
24. Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation.
Lincoln DT; Singal PK; Al-Banaw A
Anticancer Res; 2007; 27(6B):4201-18. PubMed ID: 18225592
[TBL] [Abstract][Full Text] [Related]
25. Phospholipase D in the human ocular surface and in pterygium.
Tong L; Li J; Chew J; Tan D; Beuerman R
Cornea; 2008 Jul; 27(6):693-8. PubMed ID: 18580262
[TBL] [Abstract][Full Text] [Related]
26. Expression of neurotrophic factors in human primary pterygeal tissue and selective TNF-alpha-induced stimulation of ciliary neurotrophic factor in pterygeal fibroblasts.
Hong S; Choi JY; Lee HK; Seong GJ; Seo KY; Kim EK; Byeon SH
Exp Toxicol Pathol; 2008 Sep; 60(6):513-20. PubMed ID: 18585018
[TBL] [Abstract][Full Text] [Related]
27. The role of substance P in the pathogenesis of pterygia.
Chui J; Di Girolamo N; Coroneo MT; Wakefield D
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4482-9. PubMed ID: 17898269
[TBL] [Abstract][Full Text] [Related]
28. Nestin expression in pterygia: potential role in angiogenesis.
Tonthat CV; Di Girolamo N
Br J Ophthalmol; 2014 Jun; 98(6):801-7. PubMed ID: 24008823
[TBL] [Abstract][Full Text] [Related]
29. Ets-1 represents a pivotal transcription factor for viral clearance, inflammation, and demyelination in a mouse model of multiple sclerosis.
Gerhauser I; Alldinger S; Baumgärtner W
J Neuroimmunol; 2007 Aug; 188(1-2):86-94. PubMed ID: 17599467
[TBL] [Abstract][Full Text] [Related]
30. Transcriptional silencing of ETS-1 efficiently suppresses angiogenesis of pancreatic cancer.
Lefter LP; Dima S; Sunamura M; Furukawa T; Sato Y; Abe M; Chivu M; Popescu I; Horii A
Cancer Gene Ther; 2009 Feb; 16(2):137-48. PubMed ID: 18772901
[TBL] [Abstract][Full Text] [Related]
31. Mechanical stretch regulates the expression of matrix metalloproteinase in rheumatoid arthritis fibroblast-like synoviocytes.
Wang P; Yang L; You X; Singh GK; Zhang L; Yan Y; Sung KL
Connect Tissue Res; 2009; 50(2):98-109. PubMed ID: 19296301
[TBL] [Abstract][Full Text] [Related]
32. Characterization of an intramolecular protein-protein interaction in c-Ets1 and its viral homologue v-Ets.
Schmidt M; Schmidt AM; Dietl J; Kammerer U
Oncol Rep; 2007 Aug; 18(2):457-63. PubMed ID: 17611671
[TBL] [Abstract][Full Text] [Related]
33. Aquaporin 1 is required for hypoxia-inducible angiogenesis in human retinal vascular endothelial cells.
Kaneko K; Yagui K; Tanaka A; Yoshihara K; Ishikawa K; Takahashi K; Bujo H; Sakurai K; Saito Y
Microvasc Res; 2008 Apr; 75(3):297-301. PubMed ID: 18275976
[TBL] [Abstract][Full Text] [Related]
34. Endothelial progenitor cells in pterygium pathogenesis.
Lee JK; Song YS; Ha HS; Park JH; Kim MK; Park AJ; Kim JC
Eye (Lond); 2007 Sep; 21(9):1186-93. PubMed ID: 16732212
[TBL] [Abstract][Full Text] [Related]
35. HIF-2alpha specifically activates the VE-cadherin promoter independently of hypoxia and in synergy with Ets-1 through two essential ETS-binding sites.
Le Bras A; Lionneton F; Mattot V; Lelièvre E; Caetano B; Spruyt N; Soncin F
Oncogene; 2007 Nov; 26(53):7480-9. PubMed ID: 17563748
[TBL] [Abstract][Full Text] [Related]
36. Ets-1 triggers and orchestrates the malignant phenotype of mammary cancer cells within their matrix environment.
Furlan A; Vercamer C; Desbiens X; Pourtier A
J Cell Physiol; 2008 Jun; 215(3):782-93. PubMed ID: 18181172
[TBL] [Abstract][Full Text] [Related]
37. PIASy controls ubiquitination-dependent proteasomal degradation of Ets-1.
Nishida T; Terashima M; Fukami K; Yamada Y
Biochem J; 2007 Aug; 405(3):481-8. PubMed ID: 17456046
[TBL] [Abstract][Full Text] [Related]
38. Defining ETS transcription regulatory networks and their contribution to breast cancer progression.
Turner DP; Findlay VJ; Moussa O; Watson DK
J Cell Biochem; 2007 Oct; 102(3):549-59. PubMed ID: 17661355
[TBL] [Abstract][Full Text] [Related]
39. CCL2 regulates angiogenesis via activation of Ets-1 transcription factor.
Stamatovic SM; Keep RF; Mostarica-Stojkovic M; Andjelkovic AV
J Immunol; 2006 Aug; 177(4):2651-61. PubMed ID: 16888027
[TBL] [Abstract][Full Text] [Related]
40. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
